We are live on ! Find out more
JCM

JS Capital Management Portfolio holdings

AUM $109M
1-Year Est. Return 34.13%
This Fund
S&P 500
This Quarter Est. Return
+83.58%
1 Year Est. Return
-34.13%
3 Year Est. Return
-16.34%
5 Year Est. Return
-37.7%
10 Year Est. Return
+464.39%
AUM
$2.09B
AUM Growth
+$155M
Cap. Flow
-$206M
Cap. Flow %
-9.87%
Top 10 Hldgs %
68.68%
Holding
224
New
87
Increased
23
Reduced
21
Closed
87

Top Sells

Rank Stock Value
1
ORLY icon
O'Reilly Automotive
ORLY
+$14.5M
2
CLVT icon
Clarivate
CLVT
+$11.4M
3
CTXS
Citrix Systems Inc
CTXS
+$8.27M
4
BABA icon
Alibaba
BABA
+$7.35M
5
DKNG icon
DraftKings
DKNG
+$5.99M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 53.49%
2 Communication Services 10.97%
3 Technology 10.84%
4 Healthcare 4.83%
5 Financials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEEV icon
126
Veeva Systems
VEEV
$33.1B
$218K 0.01%
+800
New +$224K
MAS icon
127
Masco
MAS
$14.1B
$214K 0.01%
+3,900
New +$215K
AUD
128
DELISTED
Audacy, Inc.
AUD
$195K 0.01%
+78,800
New +$161K
RYAM icon
129
Rayonier Advanced Materials
RYAM
$604M
$171K 0.01%
26,208
SXC icon
130
SunCoke Energy
SXC
$720M
$153K 0.01%
+35,200
New +$147K
PBFX
131
DELISTED
PBF LOGISTICS LP
PBFX
$138K 0.01%
+15,100
New +$134K
CNR
132
Core Natural Resources Inc
CNR
$4.02B
$134K 0.01%
+18,531
New +$97K
ALDX icon
133
Aldeyra Therapeutics
ALDX
$92.9M
$132K 0.01%
+19,200
New +$135K
TWI icon
134
Titan International
TWI
$466M
$94K ﹤0.01%
19,400
AQST icon
135
Aquestive Therapeutics
AQST
$464M
$86K ﹤0.01%
+16,000
New +$95.9K
BCLI
136
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$52K ﹤0.01%
+760
New +$104K
XCUR icon
137
Exicure
XCUR
$10.2M
$35K ﹤0.01%
+133
New +$33.3K
ADVM
138
DELISTED
Adverum Biotechnologies
ADVM
-1,140
Closed -$117K
AKBA icon
139
Akebia Therapeutics
AKBA
$354M
-14,600
Closed -$37K
AMT icon
140
American Tower
AMT
$80.8B
-4,000
Closed -$967K
AR icon
141
Antero Resources
AR
$11.1B
-155,300
Closed -$427K
ARCT icon
142
Arcturus Therapeutics
ARCT
$164M
-5,700
Closed -$245K
ARLP icon
143
Alliance Resource Partners
ARLP
$3.34B
-21,800
Closed -$60K
BABA icon
144
Alibaba
BABA
$293B
-25,000
Closed -$7.35M
BAH icon
145
Booz Allen Hamilton
BAH
$8.39B
-2,600
Closed -$216K
BAP icon
146
Credicorp
BAP
$31.8B
-6,200
Closed -$769K
BILL icon
147
BILL Holdings
BILL
$4.49B
-25,000
Closed -$2.51M
CACC icon
148
Credit Acceptance
CACC
$5.95B
-1,400
Closed -$474K
CCI icon
149
Crown Castle
CCI
$33.3B
-1,300
Closed -$216K
CF icon
150
CF Industries
CF
$19.2B
-15,300
Closed -$470K

Similar funds

JS Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, JS Capital Management held 224 positions worth $2.09B, up 8% from $1.94B the previous quarter. Its ten largest holdings account for 69% of the portfolio.

JS Capital Management withdrew a net $206M in Q4 2020, closing 87 positions and reducing 21 holdings. Its most notable exit was Alibaba, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 53% of assets, up from 22% a quarter earlier, followed by Communication Services and Technology.

Against the trend, JS Capital Management opened a new position in ContextLogic worth $190M.

  • JS Capital Management's largest Q4 2020 buy was ContextLogic: 346,821 shares worth $190M.
  • JS Capital Management added most to Carvana in Q4 2020, an estimated $30.4M increase.
  • JS Capital Management's biggest Q4 2020 reduction was O'Reilly Automotive, cutting an estimated $14.5M.
  • JS Capital Management fully exited Alibaba in Q4 2020, selling an estimated $7.35M.
  • JS Capital Management's ten largest holdings make up 69% of its $2.09B portfolio in Q4 2020.
  • JS Capital Management opened 87 new positions and closed 87 in Q4 2020.
  • JS Capital Management's portfolio value rose 8% quarter-over-quarter to $2.09B.

Based on JS Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.